A new class of biologics in the PCSK9 Inhibitors likely will be approved for treating high cholesterol. How are you preparing?
February 17, 2015
Conducting budgetary impact analyses
Conducting pre-approval clinical review thru P&T
Developing pre-approval prior authorization criteria
Nothing of yet, waiting til FDA approval